Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant

Maura Faraci; Daniela Cuzzubbo; Edoardo Lanino; Eddi Di Marco; Carmela Cirillo; Sandro Dallorso; Giuseppe Morreale; Cristina Moroni; Elio Castagnola

doi:10.1097/INF.0b013e3181812cb9

Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant

Maura Faraci, Daniela Cuzzubbo, Edoardo Lanino, Eddi Di Marco, Carmela Cirillo, Sandro Dallorso, Giuseppe Morreale, Cristina Moroni, Elio Castagnola

Istituto "Giannina Gaslini"

Research output: Contribution to journal › Article › peer-review

Abstract

We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis. Clinical improvement was observed in all cases, without adverse events, although significant reduction of urinary viral load was observed 2 weeks after the end of cidofovir in 5 out of 6 patients who completed the treatment.

Original language	English
Pages (from-to)	55-57
Number of pages	3
Journal	Pediatric Infectious Disease Journal
Volume	28
Issue number	1
DOIs	https://doi.org/10.1097/INF.0b013e3181812cb9
Publication status	Published - Jan 2009

Keywords

BK virus
cidofovir
hemorrhagic cystitis
probenecid

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Infectious Diseases
Microbiology (medical)

Access to Document

10.1097/INF.0b013e3181812cb9

Fingerprint Dive into the research topics of 'Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant'. Together they form a unique fingerprint.

Cite this

Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant. / Faraci, Maura; Cuzzubbo, Daniela; Lanino, Edoardo ; Di Marco, Eddi; Cirillo, Carmela; Dallorso, Sandro; Morreale, Giuseppe; Moroni, Cristina; Castagnola, Elio.

In: Pediatric Infectious Disease Journal, Vol. 28, No. 1, 01.2009, p. 55-57.

Research output: Contribution to journal › Article › peer-review

Faraci, Maura ; Cuzzubbo, Daniela ; Lanino, Edoardo ; Di Marco, Eddi ; Cirillo, Carmela ; Dallorso, Sandro ; Morreale, Giuseppe ; Moroni, Cristina ; Castagnola, Elio. / Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant. In: Pediatric Infectious Disease Journal. 2009 ; Vol. 28, No. 1. pp. 55-57.

@article{1e383ede92c6445ba0b06f85a6367282,

title = "Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant",

abstract = "We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis. Clinical improvement was observed in all cases, without adverse events, although significant reduction of urinary viral load was observed 2 weeks after the end of cidofovir in 5 out of 6 patients who completed the treatment.",

keywords = "BK virus, cidofovir, hemorrhagic cystitis, probenecid",

author = "Maura Faraci and Daniela Cuzzubbo and Edoardo Lanino and {Di Marco}, Eddi and Carmela Cirillo and Sandro Dallorso and Giuseppe Morreale and Cristina Moroni and Elio Castagnola",

year = "2009",

month = jan,

doi = "10.1097/INF.0b013e3181812cb9",

language = "English",

volume = "28",

pages = "55--57",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant

AU - Faraci, Maura

AU - Cuzzubbo, Daniela

AU - Lanino, Edoardo

AU - Di Marco, Eddi

AU - Cirillo, Carmela

AU - Dallorso, Sandro

AU - Morreale, Giuseppe

AU - Moroni, Cristina

AU - Castagnola, Elio

PY - 2009/1

Y1 - 2009/1

N2 - We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis. Clinical improvement was observed in all cases, without adverse events, although significant reduction of urinary viral load was observed 2 weeks after the end of cidofovir in 5 out of 6 patients who completed the treatment.

AB - We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis. Clinical improvement was observed in all cases, without adverse events, although significant reduction of urinary viral load was observed 2 weeks after the end of cidofovir in 5 out of 6 patients who completed the treatment.

KW - BK virus

KW - cidofovir

KW - hemorrhagic cystitis

KW - probenecid

UR - http://www.scopus.com/inward/record.url?scp=66149101543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149101543&partnerID=8YFLogxK

U2 - 10.1097/INF.0b013e3181812cb9

DO - 10.1097/INF.0b013e3181812cb9

M3 - Article

C2 - 19057462

AN - SCOPUS:66149101543

VL - 28

SP - 55

EP - 57

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 1

ER -

Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this